ReviewJournal of gynecologic oncology2020
Gynecologic oncology at the time of COVID-19 outbreak.
Review in Journal of gynecologic oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Comparison of the Efficacy and Safety of PARP Inhibitors as a Monotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis.Frontiers in oncology · 2021Pooled it
- Article
- Impact of healthcare restrictions due to COVID-19 on early pregnancy complications: A cross-sectional study.Qatar medical journal · 2025Article
- Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemic.Archives of gynecology and obstetrics · 2024Article
- The Future in Standards of Care for Gynecologic Laparoscopic Surgery to Improve Training and Education.Journal of clinical medicine · 2022Review
- Patient perspectives and experiences of the rapid implementation of digital consultations during COVID-19 - a qualitative study among women with gynecological cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care.Gynecologic oncology reports · 2022Article
- Impact of COVID-19 on gynaecological patient care: results of patient's survey with 327 patients.Archives of gynecology and obstetrics · 2022Article
- The impact of the COVID-19 pandemic on palliative care practice: A survey of clinical oncologists.Frontiers in public health · 2022Article
- Building a Personalized Medicine Infrastructure for Gynecological Oncology Patients in a High-Volume Hospital.Journal of personalized medicine · 2021Review
- Indirect effects of COVID-19 in referring women to gynecologic oncology, perinatology and gynecology clinics in Iran.Archives of gynecology and obstetrics · 2021Article
- Effect of multimodal analgesia on gynecological cancer patients after radical resection.American journal of translational research · 2021Article
- Undergoing active treatment for gynecologic cancer during COVID-19: A qualitative study of the impact on healthcare and social support.Gynecologic oncology reports · 2020Review
- Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups.Journal of gynecologic oncology · 2020Article
- Gynaecologic cancer care during COVID-19 pandemic in India: a social media survey.Cancer reports (Hoboken, N.J.) · 2020Article
- Management of patients with ovarian cancer in the COVID-19 era.Journal of surgical oncology · 2020Article
- Cancer patients affected by COVID-19: Experience from Milan, Lombardy.Gynecologic oncology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The World Health Organization (WHO) classified the novel coronavirus (i.e., coronavirus disease 2019 [COVID-19]) as a global public health emergency. COVID-19 threatens to curtail patient access to evidence-based treatment. Medicine is changing, basically due to the limited available resources. In the field of gynecologic oncology, we have to re-design our treatments' paradigm. During COVID-19 pandemic outbreak, the highest priority is to achieve the maximum benefit from less demanding procedures. Extensive procedures should be avoided, in order to reduce hospitalization and postoperative events that might increase the in-hospital spread of the virus. There are ongoing concerns on the use of laparoscopic procedures, related to the possible contamination of the staff working in the operation room. Other minimally invasive techniques, including, vaginal surgery as well as robotic-assisted and isobaric procedures would be preferred over laparoscopy. A fair allocation of resources is paramount adequate treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.